Hypertension Trial, Recruiting NCT07363343 Sponsor: The Cleveland Clinic Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07363343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older who have recently given birth
  • People who have been diagnosed with a blood pressure condition during pregnancy, such as gestational hypertension, chronic hypertension, or preeclampsia (with or without severe features)
  • People currently taking Nifedipine 60 mg every 12 hours to manage blood pressure
  • People whose blood pressure has remained at or above 140/90 mmHg over a 24-hour period, or who have had at least one reading at or above 160/110 mmHg requiring an additional blood pressure medication
  • People who speak English

Who may not be able to join:

  • People who were taking two or more blood pressure medications during pregnancy
  • People who have a condition called heart block (a problem with the heart's electrical signals)
  • People whose resting heart rate is below 60 or above 120 beats per minute
  • People who have heart failure
  • People with a blood test result showing creatinine levels above 1.5 mg/dL, which can indicate reduced kidney function (confirm with trial site)
  • People who have a narrowing of the arteries that supply the kidneys, known as renal artery stenosis
  • People with an active connective tissue disease, such as lupus or similar conditions
  • People who have had a stroke
  • People for whom treatment with nifedipine, enalapril, or labetalol has not worked or is medically unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amol Malshe, M.D., The Cleveland Clinic

Phone: 216 903-9646

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
31 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite postpartum hypertension treatment failure within 6 weeks postpartum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov